Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 14, 2022 - Issue
Submit an article Journal homepage
418
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Cost-Effectiveness Analysis of Antithyroid Drug (Propylthiouracil) Compared to Radioactive Iodine for the Treatment of Graves’ Disease in Ethiopia

Habtamu Solomon Mengistu1 Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and Health Sciences, Mizan-Tepi University, Mizan-Aman, EthiopiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8326-7998View further author information
ORCID Icon,
Kidus Tesfaye Getahun2 St. Peter’s Specialized Hospital, Federal Ministry of Health, Addis Ababa, EthiopiaView further author information
,
Lake Alemayehu3 Addis Ababa Health Bureau, Federal Ministry of Health, Addis Ababa, EthiopiaView further author information
&
Sifrash Gezahign3 Addis Ababa Health Bureau, Federal Ministry of Health, Addis Ababa, EthiopiaView further author information
Pages 221-229 | Published online: 11 Apr 2022

References

  • Food, Medicine and Health Care Administration and Control Authority. Standard Treatment Guidelines General Hospitals. 3rd. Food, Medicine and Health Care Administration and Control Authority; 2014.
  • De Leo S, Lee YS. Braverman LE Hyperthyroidism. HHS Public Access. 2016;388(10047):906–918.
  • Ethiopia DHS. Final Report Central Statistical Agency Addis Ababa. Ethiopia DHS; 2011.
  • Ogbera AO, Kuku SF. Epidemiology of thyroid diseases in Africa. Indian J Endocrinol Metab. 2011;15(Suppl2):582.
  • Nyström HF, Jansson S, Berg G. Incidence rate and clinical features of hyperthyroidism in a long‐term iodine sufficient area of Sweden (Gothenburg) 2003–2005. Clin Endocrinol (Oxf). 2013;78(5):768–776.
  • Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ. 2006;332(7554):1369.
  • Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2016;93(5):363–370.
  • Abraham P, Acharya S. Current and emerging treatment options for Graves’ hyperthyroidism. Ther Clin Risk Manag. 2010;6:29.
  • Rajput R, Goel V. Indefinite antithyroid drug therapy in toxic Graves’ disease: what are the cons. Indian J Endocrinol Metab. 2013;17(Suppl1):588.
  • Komorowski M, Raffa J. Markov models and cost-effectiveness analysis: applications in medical research. Secondary Analysis Electronic Health Rec. 2016;2:351–367.
  • In H, Pearce EN, Wong AK, Burgess JF, McAneny DB, Rosen JE. Treatment options for Graves’ disease: a cost-effectiveness analysis. J Am Coll Surg. 2009;209(2):170–179.
  • Patel NN, Abraham P, Buscombe J, Vanderpump MPJ. The Cost-Effectiveness of Treatment Modalities for Thyrotoxicosis in a U.K. Center. Eur J Endocrinol. 2006;16:6.
  • Onimode YA, Ejeh JE, Orunmuyi AT. Adverse reactions to radioiodine 131I therapy of goiter in West African tertiary hospital. Mol Imaging Radionucl Ther. 2016;25(3):128.
  • Sundaresh V, Brito JP, Wang Z, et al. Comparative effectiveness of therapies for Graves’ hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2013;98(9):3671–3677.
  • Hernández-Jiménez S, Pachón-Burgos Á, Aguilar-Salinas CA, et al. Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage. Arch Med Res. 2007;38(2):185–189.
  • Azizi F, Ataie L, Hedayati M, Mehrabi Y, Sheikholeslami F. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. Eur J Endocrinol. 2005;152(5):695–701.
  • Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593–646.
  • Abraham-Nordling M, Törring O, Hamberger B, et al. Graves’ disease: a long-term quality-of-life follow-up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 2005;15(11):1279–1286.
  • Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf). 2004;61:641–648.
  • Donovan PJ, McLeod DS, Little R, Gordon L. Cost-utility analysis comparing radioactive iodine, anti-thyroid drugs and total thyroidectomy for primary treatment of Graves’ disease. Eur J Endocrinol. 2016;175(6):595–603.
  • Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves’ disease. A prospective study. Eur J Endocrinol. 2004;151(5):549–555.
  • Yano F, Watanabe S, Hayashi K, et al. Cost-Effectiveness Analysis of Antithyroid Drug Therapy, 131I Therapy and Subtotal Thyroidectomy for Graves’ Disease. Eur J Endocrinol. 2007;56:65–76).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.